Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan

International Journal of Hematology
Masahiro ImamuraYoshihisa Kodera

Abstract

A nationwide survey of hematopoietic cell transplantation (HCT) was started in Japan in 1991, and the analyzed survey data have been presented as the annual report of the Japan Society for Hematopoietic Cell Transplantation. The 10-year overall survival (OS) rates after HCT for each disease are as follows: acute myelogenous leukemia, 44.2%; acute lymphocytic leukemia, 33.7%; adult T-cell leukemia, 24.6%; chronic myelogenous leukemia, 53.3%; myelodysplastic syndrome, 37.3%; non-Hodgkin's lymphoma, 41.5%; Hodgkin's lymphoma, 50.8%; aplastic anemia, 72.5%; breast cancer, 37.1%; germ cell tumor, 52.6%; and ovarian cancer, 44.2%. The 5-year OS rates for multiple myeloma and lung cancer were 40.6% and 23.6%, respectively. Except in cord blood transplantation, engraftment was accomplished in more than 90% of patients. The respective frequencies of acute graft-versus-host disease (GVHD) and chronic GVHD were 41.1% and 34.9% for related bone marrow transplantation (BMT), 66.8% and 34.5% for unrelated BMT, 52.9% and 36.0% for allogeneic peripheral blood stem cell transplantation, and 53.3% and 32.1% for allogeneic cord blood transplantation. OS for each disease was analyzed by patient age, stem cell source, donor type, disease status, an...Continue Reading

References

Mar 4, 1993·The New England Journal of Medicine·N A KernanJ McCullough
Dec 24, 1997·Bone Marrow Transplantation·H GondoY Niho
Apr 2, 1998·The New England Journal of Medicine·J A HansenC Anasetti
May 15, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M Vose
Nov 25, 2000·British Journal of Haematology·J Barrett, R Childs
Aug 7, 2001·Seminars in Hematology·W I BensingerR Storb
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ashraf BadrosGuido Tricot
May 9, 2003·The New England Journal of Medicine·J Anthony ChildUNKNOWN Medical Research Council Adult Leukaemia Working Party
Jun 13, 2003·Oncology·Leona A Holmberg, F Marc Stewart
Aug 22, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Patrick J StiffUNKNOWN Southwest Oncology Group
Sep 13, 2003·Blood·Bart BarlogieJohn Crowley
Mar 3, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Anna NordlanderMats Remberger
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shigesaburo MiyakoshiShuichi Taniguchi
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael G KiehlOlle Ringden
Sep 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xavier ThomasDenis Fiere
Sep 16, 2004·Springer Seminars in Immunopathology·Yago NietoElizabeth J Shpall
Feb 1, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yvette L KasamonIan W Flinn
Feb 21, 2006·Bone Marrow Transplantation·J R PasswegC Bredeson
Aug 8, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Angela R SmithMargaret L Macmillan

❮ Previous
Next ❯

Citations

Jun 5, 2007·Cell and Tissue Banking·Asen ZlatevElissaveta Naumova
Mar 2, 2010·Bone Marrow Transplantation·A YoshimiUNKNOWN Asia-Pacific Blood and Marrow Transplantation Group (APBMT)
Feb 26, 2008·International Journal of Radiation Oncology, Biology, Physics·M Loes van Kempen-HarteveldHenk Struikmans
May 21, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Takehiko MoriShinichiro Okamoto
Dec 1, 2007·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Masahiro Imamura
Dec 2, 2009·The Korean Journal of Internal Medicine·Masahiro Imamura, Junji Tanaka
Aug 4, 2007·British Journal of Haematology·James A StrauchenJames F Holland

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

© 2021 Meta ULC. All rights reserved